HLA Class I Antibody |
|||
45353-100ul | SAB | 100ul | 302.4 EUR |
HLA Class I Antibody |
|||
45353-50ul | SAB | 50ul | 224.4 EUR |
HLA-Class I Antibody |
|||
abx139485-01mg | Abbexa | 0.1 mg | 493.2 EUR |
HLA-Class I Antibody |
|||
abx139486-01mg | Abbexa | 0.1 mg | 493.2 EUR |
HLA-Class I Antibody |
|||
abx139487-01mg | Abbexa | 0.1 mg | 427.2 EUR |
HLA-Class I Antibody |
|||
abx139488-01mg | Abbexa | 0.1 mg | 444 EUR |
HLA-Class I Antibody |
|||
abx139489-01mg | Abbexa | 0.1 mg | 444 EUR |
HLA Class I Antibody |
|||
ABD8558 | Lifescience Market | 100 ug | 525.6 EUR |
HLA Class I Antibody |
|||
DF2939 | Affbiotech | 200ul | 420 EUR |
HLA Class I Antibody |
|||
DF13389 | Affbiotech | 100ul | 420 EUR |
HLA Class I Antibody |
|||
DF8558 | Affbiotech | 200ul | 420 EUR |
HLA class I (HLA-A) Antibody |
|||
abx233895-100ug | Abbexa | 100 ug | 661.2 EUR |
HLA class I (HLA-A) Antibody |
|||
abx233896-100ug | Abbexa | 100 ug | 661.2 EUR |
HLA class I (HLA-B) Antibody |
|||
abx233897-100ug | Abbexa | 100 ug | 661.2 EUR |
HLA class I (HLA-C) Antibody |
|||
abx233898-100ug | Abbexa | 100 ug | 661.2 EUR |
HLA MHC Class I antibody |
|||
10R-6691 | Fitzgerald | 100 ug | 379.2 EUR |
Description: Mouse monoclonal HLA MHC Class I antibody |
|||
HLA-Class I Antibody (PE) |
|||
abx139490-01mg | Abbexa | 0.1 mg | 644.4 EUR |
HLA-Class I Antibody (PE) |
|||
abx139491-01mg | Abbexa | 0.1 mg | 644.4 EUR |
HLA-Class I Antibody (PE) |
|||
abx139492-01mg | Abbexa | 0.1 mg | 744 EUR |
HLA-Class I Antibody (Biotin) |
|||
abx139493-01mg | Abbexa | 0.1 mg | 644.4 EUR |
HLA-Class I Antibody (FITC) |
|||
abx139494-01mg | Abbexa | 0.1 mg | 644.4 EUR |
HLA Class I Conjugated Antibody |
|||
C45353 | SAB | 100ul | 476.4 EUR |
Anti-HLA Class I antibody |
|||
STJ98596 | St John's Laboratory | 200 µl | 236.4 EUR |
Description: Rabbit polyclonal to HLA Class I. |
|||
Anti-HLA Class I antibody |
|||
STJ98668 | St John's Laboratory | 200 µl | 236.4 EUR |
Description: Rabbit polyclonal to HLA Class I. |
|||
Anti-HLA-Class I antibody |
|||
STJ16100127 | St John's Laboratory | 100 µg | 573.6 EUR |
Anti-HLA-Class I antibody |
|||
STJ16100128 | St John's Laboratory | 100 µg | 738 EUR |
Anti-HLA-Class I antibody |
|||
STJ16100129 | St John's Laboratory | 100 µg | 738 EUR |
Anti-HLA-Class I antibody |
|||
STJ16100130 | St John's Laboratory | 100 µg | 738 EUR |
Anti-HLA-Class I antibody |
|||
STJ16100202 | St John's Laboratory | 100 µg | 483.6 EUR |
Anti-HLA-Class I antibody |
|||
STJ16100203 | St John's Laboratory | 100 µg | 483.6 EUR |
Anti-HLA class I (HLA-A) antibody |
|||
PAab03895 | Lifescience Market | 100 ug | 494.4 EUR |
Anti-HLA class I (HLA-B) antibody |
|||
PAab03897 | Lifescience Market | 100 ug | 494.4 EUR |
Anti-HLA class I (HLA-C) antibody |
|||
PAab03898 | Lifescience Market | 100 ug | 494.4 EUR |
anti- HLA class I(HLA-A) antibody |
|||
FNab03895 | FN Test | 100µg | 702 EUR |
Description: Antibody raised against HLA class I(HLA-A) |
|||
anti- HLA class I(HLA-A) antibody |
|||
FNab03896 | FN Test | 100µg | 702 EUR |
Description: Antibody raised against HLA class I(HLA-A) |
|||
anti- HLA class I(HLA-B) antibody |
|||
FNab03897 | FN Test | 100µg | 702 EUR |
Description: Antibody raised against HLA class I(HLA-B) |
|||
anti- HLA class I(HLA-C) antibody |
|||
FNab03898 | FN Test | 100µg | 702 EUR |
Description: Antibody raised against HLA class I(HLA-C) |
|||
HLA Class I Histocompatibility Antigen, A-68 Alpha Chain (HLA Class I) Antibody |
|||
20-abx215936 | Abbexa |
|
|
HLA-B Antibody (MHC Class I) |
|||
F54291-0.08ML | NSJ Bioreagents | 0.08 ml | 165 EUR |
HLA-B Antibody (MHC Class I) |
|||
F54291-0.4ML | NSJ Bioreagents | 0.4 ml | 379 EUR |
HLA-B Antibody (MHC Class I) |
|||
V8848-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: HLA-B belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exon 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-B alleles have been described. |
|||
HLA-B Antibody (MHC Class I) |
|||
V8848-20UG | NSJ Bioreagents | 20ug | 219 EUR |
Description: HLA-B belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exon 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-B alleles have been described. |
|||
HLA-B Antibody (MHC Class I) |
|||
V8848SAF-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: HLA-B belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exon 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-B alleles have been described. |
|||
HLA-B Antibody (MHC Class I) |
|||
V2575-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: HLA-B belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exon 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-B alleles have been described. |
|||
HLA-B Antibody (MHC Class I) |
|||
V2575-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: HLA-B belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exon 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-B alleles have been described. |
|||
HLA-B Antibody (MHC Class I) |
|||
V2575SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: HLA-B belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exon 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-B alleles have been described. |
|||
HLA-B Antibody (MHC Class I) |
|||
V2577-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes the HLA-B27 cell surface antigen on human cells. It may be used to HLA type human lymphocytes. Approximately 60% of patients with ankylosing spondylitis are HLA-B27 positive. This reagent can be used to help identify this HLA haplotype in human lymphocytes. Major histocompatibility complex (MHC) molecules form an integral part of the immune response system. They are cell-surface receptors that bind pep- tides and present them to T lymphocytes. Human leukocyte antigens (HLAs) are polymorphic members of the MHC family that are specifically involved in the presentation of antigens to the T cell receptor. There are two classes of HLA antigens: class I (HLA-A, HLA-B and HLA-C) and class II (HLA-D). Class I molecules are expressed in nearly all cells and play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum. The differential structural properties of MHC class I and class II molecules account for their respective roles in activating different populations of T lymphocytes. HLA-B encodes a membrane anchored heavy chain, which hetero-dimerizes with a light chain (b-2-Microglobulin) to form MHC-I. Polymorphisms yield hundreds of HLA-B alleles. The HLA-B27 allele appears with increased frequency in uveitis patients. |
|||
HLA-B Antibody (MHC Class I) |
|||
V2577-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This mAb recognizes the HLA-B27 cell surface antigen on human cells. It may be used to HLA type human lymphocytes. Approximately 60% of patients with ankylosing spondylitis are HLA-B27 positive. This reagent can be used to help identify this HLA haplotype in human lymphocytes. Major histocompatibility complex (MHC) molecules form an integral part of the immune response system. They are cell-surface receptors that bind pep- tides and present them to T lymphocytes. Human leukocyte antigens (HLAs) are polymorphic members of the MHC family that are specifically involved in the presentation of antigens to the T cell receptor. There are two classes of HLA antigens: class I (HLA-A, HLA-B and HLA-C) and class II (HLA-D). Class I molecules are expressed in nearly all cells and play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum. The differential structural properties of MHC class I and class II molecules account for their respective roles in activating different populations of T lymphocytes. HLA-B encodes a membrane anchored heavy chain, which hetero-dimerizes with a light chain (b-2-Microglobulin) to form MHC-I. Polymorphisms yield hundreds of HLA-B alleles. The HLA-B27 allele appears with increased frequency in uveitis patients. |
|||
HLA-B Antibody (MHC Class I) |
|||
V2577SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes the HLA-B27 cell surface antigen on human cells. It may be used to HLA type human lymphocytes. Approximately 60% of patients with ankylosing spondylitis are HLA-B27 positive. This reagent can be used to help identify this HLA haplotype in human lymphocytes. Major histocompatibility complex (MHC) molecules form an integral part of the immune response system. They are cell-surface receptors that bind pep- tides and present them to T lymphocytes. Human leukocyte antigens (HLAs) are polymorphic members of the MHC family that are specifically involved in the presentation of antigens to the T cell receptor. There are two classes of HLA antigens: class I (HLA-A, HLA-B and HLA-C) and class II (HLA-D). Class I molecules are expressed in nearly all cells and play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum. The differential structural properties of MHC class I and class II molecules account for their respective roles in activating different populations of T lymphocytes. HLA-B encodes a membrane anchored heavy chain, which hetero-dimerizes with a light chain (b-2-Microglobulin) to form MHC-I. Polymorphisms yield hundreds of HLA-B alleles. The HLA-B27 allele appears with increased frequency in uveitis patients. |
|||
Anti-HLA Class I Biotin |
|||
1B-422-C025 | ExBio | 0.025 mg | 189.6 EUR |
Anti-HLA Class I Biotin |
|||
1B-422-C100 | ExBio | 0.1 mg | 332.4 EUR |
Anti-HLA Class I FITC |
|||
1F-422-C025 | ExBio | 0.025 mg | 189.6 EUR |
Anti-HLA Class I FITC |
|||
1F-422-C100 | ExBio | 0.1 mg | 332.4 EUR |
Anti-HLA Class I PE |
|||
1P-242-C025 | ExBio | 0.025 mg | 189.6 EUR |
Anti-HLA Class I PE |
|||
1P-242-C100 | ExBio | 0.1 mg | 332.4 EUR |
Anti-HLA Class I PE |
|||
1P-363-C025 | ExBio | 0.025 mg | 189.6 EUR |
Anti-HLA Class I PE |
|||
1P-363-C100 | ExBio | 0.1 mg | 332.4 EUR |
Anti-HLA Class I PE |
|||
1P-422-C025 | ExBio | 0.025 mg | 223.2 EUR |
Anti-HLA Class I PE |
|||
1P-422-C100 | ExBio | 0.1 mg | 397.2 EUR |
Anti-HLA Class I Purified |
|||
11-242-C025 | ExBio | 0.025 mg | 124.8 EUR |
Anti-HLA Class I Purified |
|||
11-242-C100 | ExBio | 0.1 mg | 200.4 EUR |
Anti-HLA Class I Purified |
|||
11-243-C025 | ExBio | 0.025 mg | 118.8 EUR |
Anti-HLA Class I Purified |
|||
11-243-C100 | ExBio | 0.1 mg | 189.6 EUR |
Anti-HLA Class I Purified |
|||
11-363-C025 | ExBio | 0.025 mg | 124.8 EUR |
Anti-HLA Class I Purified |
|||
11-363-C100 | ExBio | 0.1 mg | 200.4 EUR |
Anti-HLA Class I Purified |
|||
11-422-C025 | ExBio | 0.025 mg | 140.4 EUR |
Anti-HLA Class I Purified |
|||
11-422-C100 | ExBio | 0.1 mg | 234 EUR |
HLA Class I Blocking Peptide |
|||
DF8558-BP | Affbiotech | 1mg | 234 EUR |
HLA class I histocompatibility antigen, alpha chain G Polyclonal Antibody |
|||
42322-100ul | SAB | 100ul | 399.6 EUR |
Anti-HLA Class I Purified Low Endotoxin |
|||
12-422-C100 | ExBio | 0.1 mg | 234 EUR |
HLA Class I Histocompatibility Antigen, Alpha Chain E (HLA-E) Antibody |
|||
abx139495-01mg | Abbexa | 0.1 mg | 493.2 EUR |
HLA Class I Histocompatibility Antigen, Alpha Chain E (HLA-E) Antibody |
|||
abx139496-01mg | Abbexa | 0.1 mg | 493.2 EUR |
HLA Class I Histocompatibility Antigen, Alpha Chain E (HLA-E) Antibody |
|||
abx139497-01mg | Abbexa | 0.1 mg | 493.2 EUR |
HLA Class I Histocompatibility Antigen, Alpha Chain E (HLA-E) Antibody |
|||
abx139498-01mg | Abbexa | 0.1 mg | 493.2 EUR |
HLA Class I Histocompatibility Antigen, Alpha Chain E (HLA-E) Antibody |
|||
20-abx006149 | Abbexa |
|
|